Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Carcinoma, Adrenal Cortical
ClinicalTrials.gov recordTREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Treatment options for stage I ACC include:
Sources: stage I ACC
Complete surgical removal of the tumor is the treatment of choice for patients with stage I ACC. The long-term survival of patients with nonfunctioning tumors is comparable with that of patients with functioning tumors. The removal of regional lymph nodes that are not clinically enlarged is not indicated.
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Treatment options for stage II ACC include:
Sources: stage II ACC
Complete surgical removal of the tumor is the treatment of choice for patients with stage II ACC. The long-term survival of patients with nonfunctioning tumors is comparable with that of patients with functioning tumors. The removal of regional lymph nodes that are not clinically enlarged is not indicated.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Treatment options for stage III ACC include:
Sources: stage III ACC
Complete surgical removal of the tumor, with or without regional lymph node dissection, is the treatment of choice for patients with stage III ACC. The treatment of patients who have tumors with local invasion, but without clinically enlarged regional lymph nodes, is complete surgical removal, as for stage I and stage II tumors. For those with enlarged regional lymph nodes, a lymph node dissection should be included in the procedure. These patients are at high risk of disease recurrence and should consider enrolling in a clinical trial.
Radiation therapy (approximately 50–70 Gy over a period of 4 weeks) may be given to patients with localized but unresectable tumors (under clinical evaluation).[1]
Sources: 1
Chemotherapy with mitotane in doses as high as 10 to 12 g/day to achieve a blood level of 14 to 20 mg/L should be considered for patients unable to undergo complete resection (under clinical evaluation). This adrenolytic drug produces useful clinical responses in about 20% to 30% of patients with measurable tumor burden.[2,3]The role of mitotane as adjuvant therapy after complete tumor resection is still unclear but should be discussed with the patient. For patients who undergo a complete resection, the role of adjuvant mitotane and radiation therapy is the same as for patients with stage I and stage II ACC.
Chemotherapy with mitotane plus streptozotocin or mitotane plus etoposide, doxorubicin, and cisplatin may be effective and has been compared in a phase III clinical trial (NCT00924144) (under clinical evaluation).[2]
Sources: NCT00924144 · 2
Many patients with functioning tumors who receive treatment experience reduced hormone production. In patients with increased hormone production, antisteroidogenic drugs, such as ketoconazole and metyrapone, and steroid receptor antagonists, such as spironolactone and mifepristone, should be considered.
Clinical trials are appropriate for newly diagnosed patients.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Treatment options for stage IV ACC include:
Sources: stage IV ACC
Chemotherapy with mitotane.
Chemotherapy with mitotane plus streptozotocin or mitotane plus etoposide, doxorubicin, and cisplatin, as evidenced by the NCT00924144 phase III clinical trial.[1]
Sources: NCT00924144 · 1
Radiation therapy to bone metastases.
Surgical removal of localized metastases, particularly for tumors that are functioning.
Insulin-like growth factor 1 receptor–inhibitors (under clinical evaluation).
Gossypol (under clinical evaluation).
Temporary palliation of disseminated ACC can sometimes be achieved with the chemotherapeutic agent mitotane. Although measurable partial remissions are unusual and are reported in only 20% to 30% of patients, palliation of hormone symptoms is commonly observed. Prolonged treatment with mitotane, however, is often limited by gastrointestinal and neurological toxicity. Local recurrences and selected sites of metastatic disease can sometimes be palliated surgically or with radiation therapy.[1,2]
Two other cytotoxic chemotherapy regimens may be effective and have been compared in a phase III clinical trial:[1]
Sources: 1
Streptozotocin plus mitotane.
Etoposide, doxorubicin, and cisplatin plus mitotane.
Clinical trials of other chemotherapy regimens are ongoing.
Many patients with functioning tumors who receive treatment experience reduced hormone production. In patients with increased hormone production, antisteroidogenic drugs, such as ketoconazole and metyrapone, and steroid receptor antagonists, such as spironolactone and mifepristone, should be considered.
Clinical trials, including phase I and II trials of newer chemotherapeutic and biological agents, are appropriate and should be considered.
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024. Captured 2026-09-09.
Deciding to treat patients with recurrent adrenocortical carcinoma (ACC), and what treatment to use, depends on many factors, including previous treatment, site of recurrence, and individual patient considerations. Local recurrence and selected sites of metastatic disease can sometimes be palliated by surgery or radiation therapy. Although recurrent ACC is not considered curable, palliation of hormonal symptoms and occasional 5-year survivals can be achieved.[1] However, substantial morbidity is associated with resection of recurrent tumors.
Sources: 1
Clinical trials, including phase I and II trials of newer chemotherapeutic and biological agents, are appropriate and should be considered.
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Different types of treatments are available for patients with adrenocortical carcinoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Sources: clinical trials · research study
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Treatment options for adrenocortical carcinoma
The following types of treatment are used:
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Surgery to remove the adrenal gland (adrenalectomy) is often used to treat adrenocortical carcinoma. Sometimes surgery is done to remove the nearby lymph nodes and other tissue where the cancer has spread.
Sources: Surgery · adrenal gland · adrenalectomy · lymph nodes · tissue
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:
Sources: Radiation therapy · x-rays · radiation · cells
External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.
Sources: External radiation therapy
Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.
Sources: Internal radiation therapy · radioactive · seeds · catheters
The way the radiation therapy is given depends on the type and stage of the cancer being treated.
Sources: stage
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Combination chemotherapy is treatment using more than one anticancer drug. The way the chemotherapy is given depends on the type and stage of the cancer being treated.
Sources: Chemotherapy · drugs · injected · vein · systemic chemotherapy · cerebrospinal fluid · organ · cavity · abdomen · Combination chemotherapy
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
New treatments being tested in clinical trials
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.
Sources: NCI website
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Immunotherapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer.
Sources: Immunotherapy · immune system
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells.
Sources: Targeted therapy
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Side effects of treatment
Treatment for adrenocortical carcinoma may cause side effects. For information about side effects caused by treatment for cancer, visit our Side Effects page.
Sources: side effects · Side Effects
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Clinical trials
For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.
Sources: clinical trial · standard treatment
Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
Clinical trials are taking place in many parts of the country. Find clinical trials for adrenocortical carcinoma at Treatment Clinical Trials for Adrenal Cortex Cancer. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: Treatment Clinical Trials for Adrenal Cortex Cancer · ClinicalTrials.gov
Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Follow-up care
As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).
Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Stage is an important factor in deciding the best treatment for adrenocortical carcinoma. Other factors, such as your preferences and overall health, are also important.
For some people, taking part in a clinical trial may be an option. Clinical trials of new cancer drugs or treatment combinations may be available. Learn more about clinical trials, including how to find and join a trial, at Cancer Clinical Trial Information for Patients and Caregivers.
Sources: Cancer Clinical Trial Information for Patients and Caregivers
Learn more about the treatments listed below at Adrenocortical Carcinoma Treatment.
Sources: Adrenocortical Carcinoma Treatment
Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Treatment of stage I adrenocortical carcinoma
Treatment of stage I adrenocortical carcinoma may include:
Sources: stage I adrenocortical carcinoma
Surgery (adrenalectomy). Nearby lymph nodes may also be removed if they are larger than normal.
Sources: Surgery · adrenalectomy · lymph nodes
A clinical trial of a new treatment.
Sources: clinical trial
Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Treatment of stage II adrenocortical carcinoma
Treatment of stage II adrenocortical carcinoma may include:
Sources: stage II adrenocortical carcinoma
Surgery (adrenalectomy). Nearby lymph nodes may also be removed if they are larger than normal.
A clinical trial of a new treatment.
Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Treatment of stage III adrenocortical carcinoma
Treatment of stage III adrenocortical carcinoma may include:
Sources: stage III adrenocortical carcinoma
Surgery (adrenalectomy). Nearby lymph nodes may also be removed if they are larger than normal.
A clinical trial of radiation therapy.
Sources: radiation therapy
A clinical trial of a new treatment.
Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Treatment of stage IV adrenocortical carcinoma
Treatment of stage IV adrenocortical carcinoma may include the following as palliative therapy to relieve symptoms and improve the quality of life:
Sources: stage IV adrenocortical carcinoma · quality of life
Chemotherapy or combination chemotherapy.
Sources: Chemotherapy · combination chemotherapy
Radiation therapy to bones or other sites where cancer has spread.
Surgery to remove cancer that has spread to tissues near the adrenal cortex.
Sources: tissues · adrenal cortex
A clinical trial of chemotherapy, immunotherapy, or targeted therapy.
Sources: immunotherapy · targeted therapy
Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.
Source updated: February 14, 2025. Captured 2026-09-09.
Treatment of recurrent adrenocortical carcinoma
Treatment of recurrent adrenocortical carcinoma may include the following as palliative therapy to relieve symptoms and improve the quality of life:
Sources: recurrent · palliative therapy · symptoms
Surgery.
Radiation therapy.
A clinical trial of chemotherapy or immunotherapy.
Carcinoma, Adrenal Cortical
ClinicalTrials.gov recordCushing's Syndrome
ClinicalTrials.gov recordAdrenocortical Carcinoma
Treatment of Recurrent Adrenocortical Carcinoma
Treatment of Stage I Adrenocortical Carcinoma
Treatment of Stage II Adrenocortical Carcinoma
Treatment of Stage III Adrenocortical Carcinoma
Treatment of Stage IV Adrenocortical Carcinoma
INDICATIONS AND USAGE CORTEF Tablets are indicated in the following conditions. 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in...
DailyMed labelINDICATIONS AND USAGE CORTROSYN ® (cosyntropin) for Injection is intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. Because of its rapid effect on the adrenal cortex it may...
DailyMed labelINDICATIONS AND USAGE Hydrocortisone tablets are indicated in the following conditions. 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be...
DailyMed labelINDICATIONS AND USAGE Hydrocortisone tablets are indicated in the following conditions. 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be...
DailyMed labelLYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC). LYSODREN is an adrenal cytotoxic agent indicated for the treatment of patients with inoperable, functional...
DailyMed labelLYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC). LYSODREN is an adrenal cytotoxic agent indicated for the treatment of patients with inoperable, functional...
DailyMed labelINDICATIONS AND USAGE Prednisolone Sodium Phosphate Oral Solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional...
DailyMed labelINDICATIONS AND USAGE Prednisolone Sodium Phosphate Oral Solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional...
DailyMed label